AstraZeneca PLC (AZN) Annual Deutsche Bank Leveraged Finance Conference (Transcript)
CHMP Endorses AstraZeneca's Fasenra in Rare Autoimmune Disease
Biogen (BIIB.US) and UCB's lupus new drug, daclizumab, late-stage trial successful, reversing early failures.
On Tuesday, BaiHealth and its Belgian partner UCB announced that the experimental lupus treatment drug Darzalex achieved the main goal in late-stage trials.
Express News | Astrazeneca Pharmaceuticals India Limited's stock price expanded by 10%.
Black Diamond Therapeutics' Lead Drug Candidate Shows Initial Anti-tumor Activity In Certain Type Of Lung Cancer Resistant To AstraZeneca's Drug
Black Diamond Reports Encouraging Phase 2 Data for BDTX-1535
AstraZeneca Antibody Drug Candidate Fails to Meet Overall Survival Goal in Breast Cancer
AstraZeneca's Cancer Drug Could Secure FDA Approval Despite Final Trial Let-Down
Shares of AAP, SHOP, GEHC, and Others Join a 'Mind the Gap' List
Exchange-Traded Funds, Equity Futures Edge Higher Pre-Bell Monday Ahead of Key Inflation Data
AstraZeneca's Inflammatory Disease Drug Recommended for EU Approval
AstraZeneca and Daiichi Sankyo Report Data From Phase III Breast Cancer Trial
AstraZeneca's Market Position and Drug Pipeline Sustain Buy Rating Despite TB01 Trial Results
Express News | Astrazeneca breast cancer treatment trial did not meet expectations
Astrazeneca (AZN.US) breast cancer treatment trial did not meet expectations, stock price pre-market fell by 1.4%.
The experimental anti-cancer drug Datoxumab, jointly developed by AstraZeneca and Daiichi Sankyo Co., Ltd., failed to prolong the survival of patients in the breast cancer treatment trial.
FDA Approves AstraZeneca FluMist 'Flu Vaccine for Self-administration
AstraZeneca's Trial Result Is Another Disappointment for Its Cancer Drug -- Market Talk
European Markets in Green as Traders Assess Latest Economic Data
AstraZeneca Hits 8-week Low
AstraZeneca's Fasenra Set to Transform EGPA Treatment